Filed: 8/14/2023ACC: 0001420506-23-001536
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 57 equity positions with a total reported market value of $302.92M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
57
Positions
$302.92M
Total AUM (reported)
11.04M
Total Shares
Allocation by class
COM$230.17M76.0%
S&P BIOTECH$24.96M8.2%
CLASS A ORD$16.83M5.6%
SPONSORED ADR$12.94M4.3%
CL A$8.67M2.9%
SPONSORED ADS$6.25M2.1%
SHS$3.11M1.0%
Portfolio Concentration
Top 3$62.28M20.6%
4–10$95.58M31.6%
11–25$95.47M31.5%
Rest$49.59M16.4%
Top 3 weight
20.6%
Top 10 weight
52.1%
Voting Authority Distribution
Total shares with voting rights: 11.04M
Sole
Full voting authority
11.04M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole57
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings57
Rows:
SPDR SER TR
SOLEShares300K
TypeSH
Market value$24.96M
8.24%
Sole
300K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares825K
TypeSH
Market value$20.49M
6.77%
Sole
825K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares330K
TypeSH
Market value$16.83M
5.56%
Sole
330K
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares360K
TypeSH
Market value$16.81M
5.55%
Sole
360K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares180K
TypeSH
Market value$16.40M
5.41%
Sole
180K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares280K
TypeSH
Market value$13.98M
4.62%
Sole
280K
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares525K
TypeSH
Market value$13.29M
4.39%
Sole
525K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares55K
TypeSH
Market value$12.71M
4.19%
Sole
55K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares550K
TypeSH
Market value$11.86M
3.92%
Sole
550K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares650K
TypeSH
Market value$10.54M
3.48%
Sole
650K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares85K
TypeSH
Market value$9.73M
3.21%
Sole
85K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares100K
TypeSH
Market value$8.93M
2.95%
Sole
100K
Shared
0.00
None
0.00
REATA PHARMACEUTICALS INC
SOLEShares85K
TypeSH
Market value$8.67M
2.86%
Sole
85K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares110K
TypeSH
Market value$7.90M
2.61%
Sole
110K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares350K
TypeSH
Market value$7.33M
2.42%
Sole
350K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$7.23M
2.39%
Sole
200K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares185K
TypeSH
Market value$7.12M
2.35%
Sole
185K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares575K
TypeSH
Market value$6.81M
2.25%
Sole
575K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares225K
TypeSH
Market value$6.21M
2.05%
Sole
225K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares240K
TypeSH
Market value$5.71M
1.88%
Sole
240K
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares190K
TypeSH
Market value$4.17M
1.38%
Sole
190K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares65K
TypeSH
Market value$4.05M
1.34%
Sole
65K
Shared
0.00
None
0.00
BEIGENE LTD
SOLEShares22.50K
TypeSH
Market value$4.01M
1.32%
Sole
22.50K
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares238.22K
TypeSH
Market value$3.92M
1.29%
Sole
238.22K
Shared
0.00
None
0.00
VIR BIOTECHNOLOGY INC
SOLEShares150K
TypeSH
Market value$3.68M
1.21%
Sole
150K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR SER TRSOLE | S&P BIOTECH | 300K | SH | $24.96M 8.24% | 300K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 825K | SH | $20.49M 6.77% | 825K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 330K | SH | $16.83M 5.56% | 330K | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 360K | SH | $16.81M 5.55% | 360K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 180K | SH | $16.40M 5.41% | 180K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 280K | SH | $13.98M 4.62% | 280K | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 525K | SH | $13.29M 4.39% | 525K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 55K | SH | $12.71M 4.19% | 55K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 550K | SH | $11.86M 3.92% | 550K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 650K | SH | $10.54M 3.48% | 650K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 85K | SH | $9.73M 3.21% | 85K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 100K | SH | $8.93M 2.95% | 100K | 0.00 | 0.00 |
REATA PHARMACEUTICALS INCSOLE | CL A | 85K | SH | $8.67M 2.86% | 85K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 110K | SH | $7.90M 2.61% | 110K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 350K | SH | $7.33M 2.42% | 350K | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 200K | SH | $7.23M 2.39% | 200K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 185K | SH | $7.12M 2.35% | 185K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 575K | SH | $6.81M 2.25% | 575K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 225K | SH | $6.21M 2.05% | 225K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 240K | SH | $5.71M 1.88% | 240K | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | COM | 190K | SH | $4.17M 1.38% | 190K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 65K | SH | $4.05M 1.34% | 65K | 0.00 | 0.00 |
BEIGENE LTDSOLE | SPONSORED ADR | 22.50K | SH | $4.01M 1.32% | 22.50K | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 238.22K | SH | $3.92M 1.29% | 238.22K | 0.00 | 0.00 |
VIR BIOTECHNOLOGY INCSOLE | COM | 150K | SH | $3.68M 1.21% | 150K | 0.00 | 0.00 |
Page 1 of 3